A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma
Translational Andrology and Urology · 2026-03 · 15 (3) · 78-78
DOI: 10.21037/tau-2025-608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Andrology and Urology, 2026-03. Verfasst von Yuelin Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Gansu Province Clinical Research Center for Urinary System Disease, Lanzhou, China.
Zitieren
APA
Du, Y., Zheng, Y., Zhang, X., Wang, H., Zhang, H., & Shang, P. (2026). A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma. Translational Andrology and Urology, 15(3), 78-78. https://doi.org/10.21037/tau-2025-608
Vancouver
Du Y, Zheng Y, Zhang X, Wang H, Zhang H, Shang P. A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma. Translational Andrology and Urology. 2026;15(3):78-78. doi:10.21037/tau-2025-608
BibTeX
@article{Du2026,
author = {Du, Yuelin and Zheng, Yanghuang and Zhang, Xiaojun and Wang, Hongbo and Zhang, Helin and Shang, Panfeng},
title = {A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma},
journal = {Translational Andrology and Urology},
year = {2026},
volume = {15},
number = {3},
pages = {78--78},
doi = {10.21037/tau-2025-608}
}
EUVIMED